Suchergebnisse - "Dexamethasone"

PubPharm (1.527)

1

Jian Y, Chang L, Shi M-X, et al. Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairment. Blood Adv. 2023;7(24):7581-7584

enthalten in: Blood advances | 2024

ErratumFor: Blood Adv. 2023 Dec 26;7(24):7581-7584. - PMID 37922425

2

A Phase II Study to Evaluate the Efficacy of Bortezomib in Combination with Thalidomide in Treatment-Naïve Waldenstrom Macroglobulinemia Patients

enthalten in: Cancer research and treatment | 2024

von Byun, J. | Shin, J. | Kim, S. | +9

3

Extramedullary relapse of multiple myeloma presenting as space-occupying lesion in liver treated with daratumumab, pomalidomide, dexamethasone and bendamustine

enthalten in: BMJ case reports | 2024

von Wadhera, S. | Jain, A. | Mitra, S. | +1

4

Efficacy and safety of daratumumab, pomalidomide, and dexamethasone versus daratumumab, carfilzomib, and dexamethasone in daratumumab-naïve relapsed multiple myeloma

enthalten in: European journal of haematology | 2024

von Dima, D. | Mansour, R. | Davis, J. | +9

5

Real-world treatment patterns in patients initiating third-line therapy for relapsed or refractory multiple myeloma in Germany, Italy, the United Kingdom, France, and Spain

enthalten in: European journal of haematology | 2024

von Lehne, M. | Kortüm, K. | Ramasamy, K. | +10

6

Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens : patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial

enthalten in: The Lancet. Haematology | 2024

von Delforge, M. | Patel, K. | Eliason, L. | +15

ErratumIn: Lancet Haematol. 2024 Mar 12;:. - PMID 38490233

7

Negative effect of paraskeletal plasmacytoma on survival of patients with transplant-ineligible newly diagnosed multiple myeloma

enthalten in: Annals of hematology | 2024

von Wang, J. | Song, X. | Zhang, X. | +5

8

Real-world treatment patterns and outcomes for patients with multiple myeloma in Denmark, Finland and Sweden : An analysis using linked Nordic registries

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Abildgaard, N. | Anttila, P. | Waage, A. | +7

9

Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma : A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Oriol, A. | Dimopoulos, M. | Schjesvold, F. | +12

10

Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma : an indirect treatment comparison

enthalten in: Leukemia & lymphoma | 2024

von Weisel, K. | Dimopoulos, M. | Beksac, M. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[153]